Marijn van Horen

• Advises Lumileds International on a definitive agreement under which San’an Optoelectronics and Inari Amertron Berhad will acquire Lumileds Holding B.V. and its European and Asian subsidiaries.

• Advised Söderberg & Partners (again and including) on the acquisition of SAA Holding B.V. (“SAA”), one of the largest independent insurance brokers in the Netherlands. With this acquisition, SAA chooses for the Söderberg & Partners model to ensure sustainable growth.

• Advised Stellantis N.V. on the legal merger between Peugeot Nederland N.V., Citroën Nederland B.V. and Opel Nederland B.V.

• Advised Lumileds, a global leader in innovative lighting solutions, in its comprehensive financial restructuring. Lumileds emerged from a Chapter 11, resulting in a leadership transition and a funded debt reduction of approximately USD 1.4 billion.

• Advised TBAuctions Netherlands B.V. on its acquisition of Epic Auctions.

• Advised Bridgepoint Advisers II Limited on its acquisition of the DataExpert group, a leading provider of products and services to combat cybercrime and fraud and deliver forensic and incident response solutions.

• Advised Castik Capital S.à r.l. regarding the acquisition of a majority stake in WATR Group, a market leader in groundwater management and (ground-)water purification from funds advised by Borromin Capital.

• Advised Castik Capital on its acquisition of the Andra Tech Group, a leading group of companies specialising in the manufacturing of high-precision, complex components for €500-1000 million.

• Advised Sopra Steria Group SA (Euronext Paris), a European Tech leader recognised for its consulting, digital services and software development, on its recommended public offer for all ordinary shares in the capital of Ordina N.V. (Euronext Amsterdam), a Benelux-based consulting and IT services provider.

• Assisted e& in forming a strategic joint venture with PPF Telecom Group. e& acquired a controlling stake (50% plus one economic share) in PPF Telecom Group. The transaction value is EUR 2.15 billion, with a potential earn-out of up to EUR 350 million.

• Advised Frazier Lifesciences Acquisition Corporation (SPAC) on its intended business combination with NewAmsterdam Pharma and listing of the combined entity on Nasdaq.

• Advised Castik Capital S.a.r.l. on the acquisition of paraDIGMA Group.

• Represented Fortenova Group, the largest food producer and retailer in South-Eastern Europe with an annual turnover of EUR 5 billion and 47.500 employees, in the implementation of a comprehensive restructuring resulting from the presence of sanctioned debt and equity holders in its capital structure and cross-border litigation in connection therewith.

• Advised European Healthcare Acquisition Growth Company B.V., a Euronext Amsterdam-listed special purpose acquisition company (SPAC), on the intended business combination with Croma-Pharma GmbH.